|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/496 | |
| A61K 31/365 | |||
| A61K 31/137 | |||
| A61K 31/34 | |||
| A61P 3/04 |
| (11) | Number of the document | 1912650 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06764270.2 |
| Date of filing the European patent application | 2006-07-31 | |
| (97) | Date of publication of the European application | 2008-04-23 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2006/064825 |
| Date | 2006-07-31 |
| (87) | Number | WO 2007/014929 |
| Date | 2007-02-08 |
| (30) | Number | Date | Country code |
| 05016867 | 2005-08-03 | EP |
| (72) |
CECI, Angelo, DE
SCHINDLER, Marcus, DE
|
| (73) |
Sprout Pharmaceuticals, Inc.,
400 Somerset Corporate Blvd., Bridgewater, NJ 08807,
US
|
| (54) | USE OF FLIBANSERIN IN THE TREATMENT OF OBESITY |
| USE OF FLIBANSERIN IN THE TREATMENT OF OBESITY |